Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein

Virology

Volumn 257, Issue 2, 1999, Pages 277-284

  Mesnard, Jean Michel ^a   Devaux, Christian ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAX PROTEIN;

CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0033541953     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9685     Document Type: Article

References (101)

1. Adya N., Giam C.-Z. Distinct regions in human T-cell lymphotropic virus type 1 Tax mediate interactions with activator protein CREB and basal transcription factors. J. Virol. 69:1995;1834-1841.
2. Ink4Waf1/Cip1/Sdi1. Oncogene. 12:1996;1645-1652.
3. Akagi T., Ono H., Tsuchida N., Shimotohno K. Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1. FEBS Lett. 406:1997;263-266.
4. Ashkenazi A., Dixit V. M. Death receptors: Signaling and modulation. Science. 281:1998;1305-1308.
5. Baranger A. M., Palmer C. R., Hamm M. K., Glebler H. A., Brauweiler A., Nyborg J. K., Schepartz A. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature. 376:1995;606-608.
6. Bex F., Yin M. J., Burny A., Gaynor R. B. Differential transcription activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol. Cell. Biol. 18:1998;2392-2405.
7. Brauweiler A., Garrus J. E., Reed J. C., Nyborg J. K. Repression of Bax gene expression by the HTLV-I Tax protein: Implications for suppression of apoptosis in viral-infected cells. Virology. 231:1997;135-140.
8. II. Proc. Natl. Acad. Sci. USA. 94:1997;3662-3667.
9. Caron C., Rousset R., Béraud C., Moncollin V., Egly J.-M., Jalinot P. Functional and biochemical interaction of the HTLV-I Tax 1 transactivator with TBP. EMBO J. 12:1993;4269-4278.
10. waf1/cip1. Blood. 88:1996;1551-1560.
11. Chen X., Zachar V., Zdravkovic M., Guo M., Ebbesen P., Liu X. Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator. J. Gen. Virol. 78:1997;3277-3285.
12. Chlichlia K., Busslinger M., Peter M. E., Walczak H., Krammer P. H., Schirrmacher V., Khazaie K. ICE-proteases mediate HTLV-I Tax-induced apoptosis T-cell death. Oncogene. 14:1997;2265-2272.
13. Chlichlia K., Moldenhauer G., Daniel P. T., Busslinger M., Gazzolo L., Schirrmacher V., Khazaie K. Immediate effects of reversible HTLV-1tax. Oncogene. 10:1995;269-277.
14. Clemens K. E., Piras G., Radonovich M. F., Choi K. S., Duvall J. F., DeJong J., Roeder R., Brady J. N. Interaction of the human T-cell lymphotropic virus type 1 Tax transactivator with transcription factor IIA. Mol. Cell. Biol. 16:1996;4656-4664.
15. Clurman B. E., Sheaff R. J., Thress K., Groudine M., Roberts J. M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990.
16. Colgin M. A., Nyborg J. K. The human T-cell leukemia virus type I oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J. Virol. 72:1998;9396-9399.
17. Copeland K. F. T., Haaksma A. G. M., Goudsmit J., Krammer P. H., Heeney J. L. Inhibition of apoptosis in T cells expressing human T cell leukemia type I Tax. AIDS Res. Hum. Retroviruses. 10:1994;1259-1268.
18. Coscoy L., Gonzalez-Dunia D., Tangy F., Syan S., Brahic M., Ozden S. Molecular mechanism of tumorigenesis in mice transgenic for the human T-cell leukemia vitusTax. Virology. 248:1998;332-341.
19. Diehl J. A., Zindy F., Sherr C. J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 15:1997;957-972.
20. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Volgelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
21. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1326.
22. I+. J. Virol. 67:1993;7701-7704.
23. Fujita M., Shiku H. Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-Itax. Oncogene. 11:1995;15-20.
24. Gachon F., Péléraux A., Thébault S., Dick J., Lemasson I., Devaux C., Mesnard J. M. CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J. Virol. 10:1998;8332-8337.
25. Gartenhaus R. B., Wang P. Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia. 9:1995;2082-2086.
26. Gessain A., Vernant J. C., Maurs L., Gout O., Calander A., De Thé G. Antibodies to human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
27. Giebler H. A., Loring J. E., Van Orden K., Colgin M. A., Garrus J. E., Escudero K. W., Brauweiler A., Nyborg J. K. Anchoring of CREB binding protein to the human T-cell leukemia virus type I promoter: A molecular mechanism of Tax transactivation. Mol. Cell. Biol. 17:1997;5156-5164.
28. Gottlieb T. M., Oren M. p53 in growth control and neoplasia. Biochem. Biophys. Acta. 1287:1996;77-102.
29. Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type I X-region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:1992;4570-4575.
30. Grassmann R., Dengler C., Muller-Fleckenstein I., McGuire K., Dokhler M. C., Sodroski J. G., Haseltine W. A. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA. 86:1989;3351-3355.
31. Grossman W. J., Kimata J. T., Wong F.-H., Zutter M., Ley T. J., Ratner L. Development of leukemia in mice transgenic for thetax. Proc. Natl. Acad. Sci. USA. 92:1995;1057-1061.
32. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
33. Helin K., Harlow E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3:1993;43-46.
34. Hidaka M., Inoue J., Yoshida M., Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:1988;519-523.
35. Hinrichs S. H., Nerenberg M., Reynolds R. K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science. 237:1987;1340-1343.
36. Hiscott J., Petropoulos L., Lacoste J. Molecular interactions between HTLV-1 Tax protein and the NF-κB/IκB transcription complex. Virology. 214:1995;3-11.
37. Iwanaga Y., Tsukahara T., Ohashi T., Tanaka Y., Arai M., Nakamura M., Ohtani K., Koya Y., Kannagi M., Yamamoto N., Fujii M. Human T-cell leukemia virus type 1 Tax protein abrogates interleukin-2 dependence in a mouse T-cell line. J. Virol. 73:1999;1271-1277.
38. Jeang K.-T., Widen S. G., Semmes O. J. IV, Wilson S. H. HTLV-I trans-activator protein, Tax, is a transrepressor of the human β-polymerase gene. Science. 247:1990;1082-1084.
39. Jin D.-Y., Spencer F., Jeang K.-T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 93:1998;81-91.
40. Johnson D. G., Schwarz J. K., Cress W. D., Nevins J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 365:1993;349-352.
41. Cip1. Genes Dev. 11:1997;2101-2111.
42. Kitajima I., Shinohara T., Bilakovics J., Brown D. A., Xu X., Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science. 258:1992;1792-1795.
43. Ko L. J., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
44. Koralnik I. J., Gessain A., Klotman M. E., Lo Monico A., Berneman Z. N., Franchini G. Protein isoforms encoded by thepX. Proc. Natl. Acad. Sci. USA. 89:1992;8813-8817.
45. Korber B., Okayama A., Donnelly R., Tachibana N., Essex M. Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia. J. Virol. 65:1991;5471-5476.
46. Kwok R. P. S., Laurance M. E., Lundblad J. R., Goldman P. S., Shih H.-M., Connor L. M., Marriott S. J., Goodman R. H. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the coactivator CBP. Nature. 370:1996;223-226.
47. La Thangue N. B. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:1994;108-114.
48. La Thangue N. B. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24:1996;54-59.
49. tax. J. Virol. 71:1997;1975-1983.
50. INK4A. J. Biol. Chem. 273:1998;23598-23604.
51. Linke S. P. Has the smart bomb been defused. Nature. 395:1998;13-14.
52. Los M., Khazaie K., Schulze-Osthoff K., Baeuerle P. A., Schirrmacher V., Chlichlia K. Human T cell leukemia virus-I (HTLV-I) tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J. Immunol. 161:1998;3050-3055.
53. INK4A. J. Virol. 71:1997;1956-1962.
54. INK4A. Mol. Cell. Biol. 16:1996;1047-1057.
55. Matsumoto K., Shibata H., Fujisawa J.-I., Inoue H., Hakura A., Tsukahara T., Fujii M. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 71:1997;4445-4451.
56. Mayo M. W., Wang C.-Y., Cogswell P. C., Rogers-Graham K. S., Lowe S. W., Der C. J., Baldwin A. S. Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
57. Morgan D. O. Principles of CDK regulation. Nature. 374:1995;131-134.
58. Mori N. High levels of the DNA-binding activity of E2F in adult T-cell leukemia and human T-cell leukemia virus type I-infected cells: Possible enhancement of DNA-binding of E2F by the human T-cell leukemia virus I transactivating protein, Tax. Eur. J. Haematol. 58:1997;114-120.
59. 1. J. Virol. 71:1997;3451-3457.
60. Mulloy J. C., Kislyakova T., Cereseto A., Casareto L., LoMonico A., Fullen J., Lorenzi M. V., Cara A., Nicot C., Giam C.-Z., Franchini G. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:1998;8852-8860.
61. Nagai H., Kinoshita T., Imamura J., Murakami Y., Hayashi K., Mukai K., Ikeda S., Tobinai K., Saito H., Shimoyama M., Shimotohno K. Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn. J. Cancer Res. 82:1991;1421-1427.
62. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. Thetat. Science. 237:1987;1324-1329.
63. Neuveut C., Low K. G., Maldarelli F., Schmitt I., Majone F., Grassmann R., Jeang K.-T. Human T-cell leukemia virus type 1 Tax and cell cycle progression: Role of cyclin D-cdk and p110Rb. Mol. Cell. Biol. 18:1998;3620-3632.
64. Nevins J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-429.
65. Parker S. F., Perkins N. D., Gitlin S. D., Nabel G. J. A cooperative interaction of human T-cell leukemia virus type 1 Tax with the p21 cyclin-dependent kinase inhibitor activates the human immunideficiency virus type 1 enhancer. J. Virol. 70:1996;5731-5734.
66. Perkins N. D., Felzien L. K., Betts J. C., Leung K., Beach D. H., Nabel G. J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
67. Peter M., Herskowitz I. Joining the complex cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell. 79:1994;181-184.
68. Pise-Masison C. A., Choi K.-S., Radonovich M., Dittmer J., Kim S.-J., Brady J. N. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J. Virol. 72:1998a;1165-1170.
69. Pise-Masison C. A., Radonovich M., Sakaguchi K., Appella E., Brady J. N. Phosphorylation of p53: A novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J. Virol. 72:1998b;6348-6355.
70. Pozzatti R., Vogel J., Jay G. The human T-cell leukemia virus type Itaxras. Mol. Cell. Biol. 10:1990;413-417.
71. Qin X.-Q., Livingston D. M., Kaelin W. G., Adams P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;10918-10922.
72. Reddy T. R., Tang H., Li X., Wong-Staal F. Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4). Oncogene. 14:1997;2785-2792.
73. Reid R. L., Lindholm P. F., Mireskandari A., Dittmer J., Brady J. N. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene. 8:1993;3029-3036.
74. Rivera I., Harhaj E. W., Sun S.-C. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J. Biol. Chem. 273:1998;22382-22388.
75. Rosin O., Koch C., Schmitt I., Semmes O. J., Jeang K.-T., Grassmann R. A human T-cell leukemia virus Tax variant incapable of activating NF-κB retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 273:1998;6698-6703.
76. Ruesch M. N., Laimins L. A. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J. Virol. 71:1997;5570-5578.
77. Sakashita A., Hattori T., Miller C. W., Suzushima Y., Asou N., Takatsuki K., Koeffler H. P. Mutations of the p53 gene in adult T-cell leukemia. Blood. 79:1992;477-480.
78. 1. J. Virol. 72:1998;633-640.
79. Sherr C. J. G1-phase progression: Cycling on cue. Cell. 79:1994;551-555.
80. Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
81. Slansky J. E., Farnham P. J. Introduction of the E2F family: Protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208:1996;1-30.
82. Smith M. R., Greene W. C. Type I human T-cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J. Clin. Invest. 88:1991;1038-1042.
83. Sugito S., Yamato K., Sameshima Y., Yokota J., Yano S., Miyoshi I. Adult T-cell leukemia: Structures and expression of the p53 gene. Int. J. Cancer. 49:1991;880-885.
84. Suzuki T., Fujisawa J. I., Toita M., Yoshida M. Thetrans. Proc. Natl. Acad. Sci. USA. 90:1993;610-614.
85. INK4A. EMBO J. 15:1996;1607-1614.
86. Tanaka A., Takahashi C., Yamaoka S., Nosaka T., Maki M., Hatanaka M. Oncogenic transformation by the Tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;1071-1075.
87. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
88. Uittenbogaard M. N., Armstrong A. P., Chiaramello A., Nyborg J. K. Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J. Biol. Chem. 269:1994;22466-22469.
89. Uittenbogaard M. N., Giebler H. A., Reisman D., Nyborg J. K. Transcriptional repression ofp53. J. Biol. Chem. 270:1995;28503-28506.
90. Van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
91. Waga S., Hannon G. J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
92. Won K. A., Reed S. I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:1996;4182-4193.
93. Wu X., Levine A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;3602-3606.
94. Yamada T., Yamaoka S., Goto T., Nakai M., Tsujimoto Y., Hatanaka M. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virol. 68:1994;3374-3379.
95. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., Yamada T., Hatanaka M. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 15:1996;873-887.
96. Yamaoka S., Tobe T., Hatanaka M. Tax protein of T-cell leukemia virus type I is required for maintenance of the transformed phenotype. Oncogene. 7:1992;433-437.
97. Yamato K., Oka T., Hiroi M., Iwahara Y., Sugito S., Tsuchida N., Miyoshi I. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells. Jpn. J. Cancer Res. 84:1993;4-8.
98. Yin M.-J., Gaynor R. B. HTLV-I 21-bp repeat sequences facilitate stable association between Tax and CREB to increase CREB binding affinity. J. Mol. Biol. 264:1996;20-31.
99. Yin M.-J., Paulssen E. J., Seeler J.-S., Gaynor R. B. Protein domains involved in bothin vivoin vitro. J. Virol. 69:1995;3420-3432.
100. Yoshida M., Suzuki T., Fujisawa J., Hirai H. HTLV-1 oncoprotein Tax and cellular transcription factors. Curr. Top. Microbiol. Immunol. 193:1995;79-89.
101. Zhao L. J., Giam C.-Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator. Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA. 89:1992;7070-7074.